The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
第一作者:
Jiaojiao,Hao
第一单位:
Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
作者:
医学主题词
老年人(Aged);动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);环氧化酶2(Cyclooxygenase 2);疾病恶化(Disease Progression);抗药性, 肿瘤(Drug Resistance, Neoplasm);E1A相关p300蛋白质(E1A-Associated p300 Protein);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因敲低技术(Gene Knockdown Techniques);人类(Humans);男(雄)性(Male);黑色素瘤(Melanoma);小鼠(Mice);小鼠, 裸(Mice, Nude);中年人(Middle Aged);NF-κB(NF-kappa B);一氧化氮合酶Ⅱ型(Nitric Oxide Synthase Type II);预后(Prognosis);启动区, 遗传(Promoter Regions, Genetic);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);信号传导(Signal Transduction);皮肤(Skin);皮肤肿瘤(Skin Neoplasms);转录因子(Transcription Factors);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.jid.2017.07.850
PMID
28899685
发布时间
2024-12-06
- 浏览7
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



